| Net Income | -124.36M |
| Depreciation, Depletion and Amortization | 448.91M |
| Deferred Income Tax Expense | -59.41M |
| (Gain) / Loss on Sale of Assets | |
| Exploration Expense | 18K |
| Unrealized Loss / (Gain) on Derivative Instruments | |
| Amortization of Debt Issuance Costs | 3.89M |
| Stock-Based Compensation Expense and Other | 23.05M |
| Accounts Receivable, Net | -1.14M |
| Income Taxes | |
| Inventories | 2.86M |
| Other Current Assets | -917K |
| Accounts Payable and Accrued Liabilities | -17.23M |
| Other Assets and Liabilities | 784K |
| Net Cash Provided by Operating Activities | 252.65M |
| Capital Expenditures | -245.03M |
| Proceeds from Sale of Assets | |
| Net Cash Used in Investing Activities | -220.14M |
| Borrowings from Debt | 90M |
| Repayments of Debt | -587M |
| Dividends Paid | -26.89M |
| Capitalized Debt Issuance Costs | -3.22M |
| Other | 0 |
| Net Cash Provided by Financing Activities | 468.17M |
| Net (Decrease) / Increase in Cash and Cash Equivalents | |
| Cash and Cash Equivalents, Beginning of Period | 514K |
| Cash and Cash Equivalents, End of Period | 501.19M |